Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.
Read original article on Medical Xpress - latest medical and health news stories →